Clinical trial
Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low…
NCT00246155 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00246155 |
|---|---|
| Title | Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain |
| Official title | A Prospective Study to Evaluate the Potential Effects on Function and Size in Back Muscle After Injection of Botulinum Toxin Type A (Dysport®) in the Treatment of Chronic Low Back Pain |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Low Back Pain |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 35 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Oct 31, 2005 |
| Last update posted | Jul 26, 2019 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: